[b][/b]
[i][/i]
[u][/u]
[code][/code]
[quote][/quote]
[spoiler][/spoiler]
[url][/url]
[img][/img]
[video][/video]
Smileys
smile
smile2
spook
alien
zunge
rose
shy
clown
devil
death
sick
heart
idee
frage
blush
mad
sad
wink
frown
crazy
grin
hmm
laugh
mund
oh
rolling_eyes
oh2
shocked
cool
[pre][/pre]
Farben
[rot][/rot]
[blau][/blau]
[gruen][/gruen]
[orange][/orange]
[lila][/lila]
[weiss][/weiss]
[schwarz][/schwarz]
elianagrace26
| Last online: 01.05.2022
avatar
Occupation
Corporate Sales Specialist
Date registered
12.28.2021
Description
The European biosimilar market was the first to be established and still represents the most mature and advancing market at a global scale owing to a large number of approved and commercially available biosimilars. Since the launch of the first biosimilar in Europe, the biosimilar market is continuously evolving and showing high adoption rates. The region represents an excellent market for the growth of biosimilars due to the presence of large pharmaceutical sector which actively indulge in research and development activities. The biosimilar market in Europe is highly competitive, with many key players dominating the market landscape including Novartis, Celltrion, Accord Healthcare, Pfizer, and Mylan.
Sex
female
No activities yet.
Recipient
elianagrace26
Subject:


text:

Sign up, to leave a comment


Xobor Einfach ein eigenes Xobor Forum erstellen
Datenschutz